Pablo Lapunzina, M.D., Ph.D. Pediatrician, clinical and molecular geneticist, and specialist in embryofetal medicine. He trained in Pediatrics and then in Medical Genetics and Dysmorphology. PhD, School of Medicine, University of Buenos Aires. He also completed 3 years of training in Molecular Genetics at the National Institute of Genetics and Molecular Biology (INGEBI-CONICET). He is currently the leader of the research group of the INGEMM (Institute of Medical and Molecular Genetics, University Hospital La Paz, Autonomous University of Madrid, Spain) and the Scientific Director of CIBERER, the Center for Biomedical Research in the Network of Rare Diseases, ISCIII, Madrid (www.ciberer.es). Associate Editor of Clinical Genetics and part of the Board of other journals such as American Journal of Medical Genetics. He is author or co-author of more than 300 articles in medical and scientific literature, 23 book chapters and 12 books. His research activity focuses on genomic disorders, overgrowth syndromes, and genetic disorders of imprinting. He received 37 grants for Research from National Agencies, The European Commission and the NIH of USA. In 2020, he completed a 6-weeks Course on Artificial Intelligence in the MIT. He has been working in Genomics and Research in Rare Diseases for 23 years at the INGEMM, Hospital Universitario La Paz, Madrid, Spain. He is also full professor of Pediatrics and Genetics at San Pablo-CEU University in Madrid, Spain.